Inflammatix (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- January 10, 2020
- Vertical
- Molecular Diagnostics
- Funding URL
- View Funding Page
- Funding Amount:
- $32,000,000
Company Info
- Company Description
- Inflammatix develops rapid immune system diagnostics to improve patient care and public health.
- Market
- Healthcare
- Location
- Burlingame, California, USA
- Coinvestors
- Grey Sky Venture Partners, Northpond Ventures, Think.Health Ventures